Generation Bio Co.GBIOEarnings & Financial Report

Nasdaq · Health Care · Pharmaceutical Preparations

Deep AnalysisCompare

Generation Bio Co. is a clinical-stage biotechnology firm focused on developing innovative non-viral gene therapies for both rare and common genetic diseases. Its core pipeline targets liver and retina disease indications, operates primarily in the U.S. market, and aims to deliver potential one-time curative treatments to patients with unmet medical needs.